DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury
DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury is a paper indexed in PICO Portal from OpenAlex.
How many citations does DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury have?
DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury has 103 citations in the OpenAlex counts PICO Portal stores.
When was DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury published?
DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury has 2017 year in the PICO Portal index.
What is the open-access status of DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury?
DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury has bronze oa status in the PICO Portal index.
What is the DOI of DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury?
The DOI for DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury is on the source record.
What is the PMID of DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury?
The PMID for DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury is on the source record.
What is the OpenAlex record for DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury?
The OpenAlex for DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury is on the source record.